Coronavirus: Indonesia says not yet able to determine Sinovac vaccine efficacy

Indonesia’s state-owned pharmaceutical company Bio Farma said late on Tuesday the efficacy of a Covid-19 vaccine developed by China’s Sinovac could not yet be determined, after previously saying that interim data showed 97 per cent efficacy.In a statement, Bio Farma said the interim report from the Phase III trial is expected to be available in January.Bambang Heriyanto, an official at Bio Farma, said efficacy cannot be determined at this time, and it was necessary to wait for complete data.Bio…

Read the original article at South China Morning Post